Experiment 773389

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVO

Compounds isolated

MYRICANOL,13-OXO:

Alerts

VS.12-O-TETRADECANOYLPHORBOL-13-ACETATE(TPA)-INDUCED CARCINOGENESIS.VS.DMBA-INDUCED CARCINOGENESIS.

Details

PropertyValue
Pharmacology
CARCINOGENESIS INHIBITION
Administration routeEXTERNAL
OrganismEmpty organism
CitationISHIDA,J: KOZUKA,M: WANG,HK: KONOSHIMA,T: TOKUDA,H: OKUDA,M: MOU,XY: NISHINO,H: SAKURAI,N: LEE,KH: NAGAI,M:. (2000). ANTITUMOR-PROMOTING EFFECTS OF CYCLIC DIARYLHEPTANOIDS ON EPSTEIN-BARR VIRUS ACTIVATION AND TWO-STAGE MOUSE SKIN CARCINOGENESIS.. 159(2)
Amount utilized
Compound isolated
Dose amount85.0 NANOMOLS
Number5
Qualitative resultACTIVE
AnimalMOUSE
Dose expressionCONC USED
GenderFEMALE